| Metastasis dormancy in estrogen receptor–positive breast cancer XHF Zhang, M Giuliano, MV Trivedi, R Schiff, CK Osborne Clinical Cancer Research 19 (23), 6389-6397, 2013 | 282 | 2013 |
| Perspective on circulating tumor cell clusters: why it takes a village to metastasize M Giuliano, A Shaikh, HC Lo, G Arpino, S De Placido, XH Zhang, ... Cancer research 78 (4), 845-852, 2018 | 224 | 2018 |
| Bidirectional crosstalk between the estrogen receptor and human epidermal growth factor receptor 2 signaling pathways in breast cancer: molecular basis and clinical implications M Giuliano, MV Trivedi, R Schiff Breast Care 8 (4), 256-262, 2013 | 196 | 2013 |
| FOXA1 overexpression mediates endocrine resistance by altering the ER transcriptome and IL-8 expression in ER-positive breast cancer X Fu, R Jeselsohn, R Pereira, EF Hollingsworth, CJ Creighton, F Li, ... Proceedings of the National Academy of Sciences 113 (43), E6600-E6609, 2016 | 165 | 2016 |
| The changing role of ER in endocrine resistance A Nardone, C De Angelis, MV Trivedi, CK Osborne, R Schiff The Breast 24, S60-S66, 2015 | 147 | 2015 |
| Biological mechanisms and clinical implications of endocrine resistance in breast cancer M Giuliano, R Schiff, CK Osborne, MV Trivedi The Breast 20, S42-S49, 2011 | 141 | 2011 |
| Upregulation of ER signaling as an adaptive mechanism of cell survival in HER2-positive breast tumors treated with anti-HER2 therapy M Giuliano, H Hu, YC Wang, X Fu, A Nardone, S Herrera, S Mao, ... Clinical Cancer Research 21 (17), 3995-4003, 2015 | 129 | 2015 |
| Oral glutamine in preventing treatment‐related mucositis in adult patients with cancer: a systematic review C Sayles, SC Hickerson, RR Bhat, J Hall, KW Garey, MV Trivedi Nutrition in Clinical Practice 31 (2), 171-179, 2016 | 89 | 2016 |
| Identifying adherence barriers to oral endocrine therapy among breast cancer survivors R Paranjpe, G John, M Trivedi, S Abughosh Breast Cancer Research and Treatment 174, 297-305, 2019 | 84 | 2019 |
| Optimal use of G-CSF administration after hematopoietic SCT M Trivedi, S Martinez, S Corringham, K Medley, ED Ball Bone marrow transplantation 43 (12), 895-908, 2009 | 83 | 2009 |
| Evaluation of In Vivo P-Glycoprotein Phenotyping Probes: A Need for Validation JD Ma, SM Tsunoda, JS Bertino, M Trivedi, KK Beale, AN Nafziger Clinical pharmacokinetics 49, 223-237, 2010 | 80 | 2010 |
| Circulating and disseminated tumor cells from breast cancer patient-derived xenograft-bearing mice as a novel model to study metastasis M Giuliano, S Herrera, P Christiny, C Shaw, CJ Creighton, T Mitchell, ... Breast cancer research 17, 1-9, 2015 | 70 | 2015 |
| Interventions to improve endocrine therapy adherence in breast cancer survivors: what is the evidence? E Ekinci, S Nathoo, T Korattyil, A Vadhariya, HA Zaghloul, PA Niravath, ... Journal of Cancer Survivorship 12, 348-356, 2018 | 68 | 2018 |
| The oral selective oestrogen receptor degrader (SERD) AZD9496 is comparable to fulvestrant in antagonising ER and circumventing endocrine resistance A Nardone, H Weir, O Delpuech, H Brown, C De Angelis, ML Cataldo, ... British journal of cancer 120 (3), 331-339, 2019 | 62 | 2019 |
| Metabolic syndrome and early stage breast cancer outcome: results from a prospective observational study G Buono, A Crispo, M Giuliano, C De Angelis, F Schettini, V Forestieri, ... Breast cancer research and treatment 182, 401-409, 2020 | 55 | 2020 |
| Rosiglitazone restores renal D1A receptor-Gs protein coupling by reducing receptor hyperphosphorylation in obese rats M Trivedi, MF Lokhandwala American Journal of Physiology-Renal Physiology 289 (2), F298-F304, 2005 | 55 | 2005 |
| Evaluation of the predictive role of tumor immune infiltrate in patients with HER2-positive breast cancer treated with neoadjuvant anti-HER2 therapy without chemotherapy C De Angelis, C Nagi, CC Hoyt, L Liu, K Roman, C Wang, Y Zheng, ... Clinical Cancer Research 26 (3), 738-745, 2020 | 46 | 2020 |
| Blockade of AP-1 potentiates endocrine therapy and overcomes resistance L Malorni, M Giuliano, I Migliaccio, T Wang, CJ Creighton, M Lupien, X Fu, ... Molecular Cancer Research 14 (5), 470-481, 2016 | 45 | 2016 |
| Epothilones: a novel class of microtubule-stabilizing drugs for the treatment of cancer M Trivedi, I Budihardjo, K Loureiro, TR Reid, JD Ma Future Oncology 4 (4), 483-500, 2008 | 43 | 2008 |
| A CTC-cluster-specific signature derived from OMICS analysis of patient-derived xenograft tumors predicts outcomes in basal-like breast cancer H Thangavel, CD Angelis, S Vasaikar, R Bhat, MK Jolly, C Nagi, ... Journal of clinical medicine 8 (11), 1772, 2019 | 38 | 2019 |
